{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T15:10:09Z","timestamp":1731251409879,"version":"3.28.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,10]]},"DOI":"10.7759\/cureus.73376","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T14:55:21Z","timestamp":1731250521000},"source":"Crossref","is-referenced-by-count":0,"title":["Drop and Swell: Unanticipated Corneal Edema From Netarsudil Therapy"],"prefix":"10.7759","author":[{"given":"Gufran A","family":"Kamdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi A","family":"Chodvadiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Paranjpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100800","article-title":"Netarsudil-associated epithelial keratopathy","volume":"19","author":"Ramakrishnan MS","year":"2020","unstructured":"Ramakrishnan MS, Addis VM, Lehman AY, Sankar PS. Netarsudil-associated epithelial keratopathy. Am J Ophthalmol Case Rep. 2020, 19:100800. 10.1016\/j.ajoc.2020.100800","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-02665-0","article-title":"Rhopressa-induced corneal edema: a case report","volume":"15","author":"Chu MJ","year":"2021","unstructured":"Chu MJ, Song M, Palmares T, Song A, Song J. Rhopressa-induced corneal edema: a case report. J Med Case Rep. 2021, 15:182. 10.1186\/s13256-021-02665-0","journal-title":"J Med Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101287","article-title":"Netarsudil-associated reticular corneal epithelial edema","volume":"25","author":"Tran JA","year":"2022","unstructured":"Tran JA, Jurkunas UV, Yin J, Davies EC, Sola-Del Valle DA, Chen TC, Lin MM. Netarsudil-associated reticular corneal epithelial edema. Am J Ophthalmol Case Rep. 2022, 25:101287. 10.1016\/j.ajoc.2022.101287","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2865_21","article-title":"Reticular epithelial corneal edema as a novel side-effect of Rho kinase inhibitors: an Indian scenario","volume":"70","author":"Bhargava M","year":"2022","unstructured":"Bhargava M, Sen S, Bhambhani V, Paul RS, Dutta C. Reticular epithelial corneal edema as a novel side-effect of Rho kinase inhibitors: an Indian scenario. Indian J Ophthalmol. 2022, 70:1163-70. 10.4103\/ijo.IJO_2865_21","journal-title":"Indian J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase\u00a0elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle JB","year":"2018","unstructured":"Serle JB, Katz LJ, McLaurin E, et al.. Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: Rho kinase\u00a0elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2). Am J Ophthalmol. 2018, 186:116-27. 10.1016\/j.ajo.2017.11.019","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.03.002","article-title":"Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study","volume":"204","author":"Khouri AS","year":"2019","unstructured":"Khouri AS, Serle JB, Bacharach J, et al.. Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study. Am J Ophthalmol. 2019, 204:97-104. 10.1016\/j.ajo.2019.03.002","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_2_22","article-title":"Reticular corneal epithelial edema with topical netarsudil","volume":"16","author":"Parmar DP","year":"2023","unstructured":"Parmar DP, Bhole PK, Garde PV. Reticular corneal epithelial edema with topical netarsudil. Oman J Ophthalmol. 2023, 16:94-7. 10.4103\/ojo.ojo_2_22","journal-title":"Oman J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","volume":"217","author":"Wisely CE","year":"2020","unstructured":"Wisely CE, Liu KC, Gupta D, Carlson AN, Asrani SG, Kim T. Reticular bullous epithelial edema in corneas treated with netarsudil: a case series. Am J Ophthalmol. 2020, 217:20-6. 10.1016\/j.ajo.2020.04.002","journal-title":"Am J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275293-drop-and-swell-unanticipated-corneal-edema-from-netarsudil-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T14:55:22Z","timestamp":1731250522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275293-drop-and-swell-unanticipated-corneal-edema-from-netarsudil-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,10]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.73376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,10]]}}}